Blood Cancer Journal (Feb 2021)
Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
- Abhishek Maiti,
- Courtney D. DiNardo,
- Naval G. Daver,
- Caitlin R. Rausch,
- Farhad Ravandi,
- Tapan M. Kadia,
- Naveen Pemmaraju,
- Gautam Borthakur,
- Prithviraj Bose,
- Ghayas C. Issa,
- Nicholas J. Short,
- Musa Yilmaz,
- Guillermo Montalban-Bravo,
- Alessandra Ferrajoli,
- Elias J. Jabbour,
- Nitin Jain,
- Maro Ohanian,
- Koichi Takahashi,
- Philip A. Thompson,
- Sanam Loghavi,
- Kathryn S. Montalbano,
- Sherry Pierce,
- William G. Wierda,
- Hagop M. Kantarjian,
- Marina Y. Konopleva
Affiliations
- Abhishek Maiti
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Courtney D. DiNardo
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Naval G. Daver
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Caitlin R. Rausch
- Division of Pharmacy, The University of Texas MD Anderson Cancer Center
- Farhad Ravandi
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Tapan M. Kadia
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Naveen Pemmaraju
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Gautam Borthakur
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Prithviraj Bose
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Ghayas C. Issa
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Nicholas J. Short
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Musa Yilmaz
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Guillermo Montalban-Bravo
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Alessandra Ferrajoli
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Elias J. Jabbour
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Nitin Jain
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Maro Ohanian
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Koichi Takahashi
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Philip A. Thompson
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Sanam Loghavi
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center
- Kathryn S. Montalbano
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Sherry Pierce
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- William G. Wierda
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Hagop M. Kantarjian
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Marina Y. Konopleva
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- DOI
- https://doi.org/10.1038/s41408-021-00410-w
- Journal volume & issue
-
Vol. 11,
no. 2
pp. 1 – 6
Abstract
No abstracts available.
